Live Pharmaceutical Import data of Russia imports from italy under HS Code 29 via Port 10228020-customs-post , our Russia customs import data reports include date, value, quantity, product description, HS code, port, country, and Russia pharmaceutical importers data
Date |
HS Code |
Product Description |
Origin Country |
Customs |
QTY. |
Unit |
Value($) |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-04-09 00:00:00 |
2918110000
|
LACTIC ACID AND ITS ESTERS: USED AS A RAW MATERIAL FOR THE PRODUCTION OF COSMETIC PRODUCTS. NOT USED IN VETERINARY MEDICINE OR PHARMACEUTICALS. | ITALY | 10228020 CUSTOMS POST | 25 | KG | 1525 | Importer Name |
2024-04-09 00:00:00
LACTIC ACID AND ITS ESTERS: USED AS A RAW MATERIAL FOR THE PRODUCTION OF COSMETIC PRODUCTS. NOT USED IN VETERINARY MEDICINE OR PHARMACEUTICALS.
25
KG
1525
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 29 for Russia pharmaceutical imports from Thailand via Port 10228020-customs-post.
Port 10228020-customs-post typically refers to a port that is used for handling and forwarding shipments into Russia, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharmaceutical products, enabling better decision-making for trade and market expansion for Russia pharmaceutical imports from italy under HS code 29 via Port 10228020-customs-post.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharmaceutical market.
